Shareholding8 Jun 2026, 01:03 pm
Sudhir Sethi Acquires 1992 Shares of Beryl Drugs
AI Summary
Sudhir Sethi, the main promoter of Beryl Drugs Ltd, has acquired 1992 shares, representing 0.03% of the company's total voting capital. This acquisition was made through market transactions. Following this purchase, Sethi's total shareholding in Beryl Drugs increases to 4,95,975 shares, constituting 9.75% of the total equity share capital.
Key Highlights
- Promoter Sudhir Sethi acquired 1992 shares.
- Acquisition represents 0.03% of total voting capital.
- Total shareholding now stands at 9.75%.
- Acquisition was made via market transactions.
Price Impact
More from BERLDRG